Epigenomics' FY 2010 Revenues Fall 58 Percent | GenomeWeb

By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – Epigenomics today reported that its full-year 2010 revenues declined 58 percent, due to non-recurring revenue in 2009 tied to R&D support for partners.

The Berlin, Germany-based firm said that its 2010 revenues were €1.8 million ($2.6 million), down from €4.3 million in 2009.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.